Sumages Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.17 M
as on 11-12-2024
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.21 Cr
as on 11-12-2024
- Satisfied Charges ₹ 1.02 Cr
as on 11-12-2024
- Revenue -33.00%
(FY 2022)
- Profit 1033.44%
(FY 2022)
- Ebitda 40.97%
(FY 2022)
- Net Worth 30.02%
(FY 2022)
- Total Assets -12.67%
(FY 2022)
About Sumages Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.17 M.
The company currently has active open charges totaling ₹1.21 Cr. The company has closed loans amounting to ₹1.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Someswara Manepalli and Raghva Manepalli serve as directors at the Company.
- CIN/LLPIN
U24239AP1985PTC005817
- Company No.
005817
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
West Godavari, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sumages Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Someswara Manepalli  | Director | 29-May-2013 | Current |
| Raghva Manepalli | Director | 20-Aug-2018 | Current |
Financial Performance of Sumages Pharma.
Sumages Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33% decrease. The company also saw a substantial improvement in profitability, with a 1033.44% increase in profit. The company's net worth Soared by an impressive increase of 30.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sumages Pharma?
In 2022, Sumages Pharma had a public holding of 26.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mmc Health Care LimitedActive 28 years 9 monthsSomeswara Manepalli and Raghva Manepalli are mutual person
Suraksha Pharma Private LimitedActive 26 years 7 monthsSomeswara Manepalli and Raghva Manepalli are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 May 2016 | ₹1.21 Cr | Open |
A.P. State Financial Corporation Creation Date: 19 Jul 1997 | ₹1.00 M | Satisfied |
Lakshmi General Finance Ltd. Creation Date: 07 Apr 1997 | ₹0.21 M | Satisfied |
How Many Employees Work at Sumages Pharma?
Unlock and access historical data on people associated with Sumages Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sumages Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sumages Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
